| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.59 | 0.04 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.006 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.2 | 0.02 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.16 | 0.06 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.14 | 0.6 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |